References
- Levine R.R. Am. J. Dig. Dis. 1970; 15: 171
- Benet L.Z., Greither A. Meister. “The Effect of Disease States on Drug Pharmacokinetics,”, L.Z. Benet. Am. Pharm. Assoc. - Acad. Pharm. Sci., Washington, D.C. 1976, Chap. 3, 33
- Wilkinson G.R., Shand D.G. Clin. Pharmacol. Therap. 1975; 18: 377
- Rowland M., Blaschke T.F., Meffin P.J., Williams R.L. “The Effect of Disease States on Drug Pharmacokinetics,”, L.Z. Benet. Am. Pharm. Assoc, Washington 1976, Chap. 4, p. 53
- Pang K.S. Trends Pharmacol. Sci. 1980; 247
- Wagner J. J. Pharmacokin. Biopharm. 1973; 1: 165
- Alvares A.P., Kappas A., Eiseman J.L. Clin. Pharmacol. Therap. 1979; 26, 407
- Wagner J., Nelson E. J. Pharm. Sci. 1964; 53: 1392
- Loo J. C.K., Riegelman S. J. Pharm. Sci. 1968; 57: 918
- Boxenbaum H.G., Kaplan S.A. J. Pharmacokin. Biopharm. 1975; 3, 257
- Graffner C., Johnsson G., Sjogren J. Clin. Pharmacol. Therap. 1975; 17: 414
- Riegelman S. “Aspirin, Platelets and Stroke,”, W.K. Hass. Warren, H. Green, Inc., St Louis 1971; 105, Chap. 10
- Rowland M., Riegelman S. J. Pharm. Sci. 1968; 57: 1313
- Hollister L.E. Clin. Pharmacol. Therap. 1972; 13: 1
- Kock-Weser J., Klein S.W. J. Am. Med. Assoc 1971; 215: 1454
- Koch-Weser J. Ann. N.Y. Acad. Sci. 1971; 179, 370
- Elson J., Strong J.M., Lee W., Atkinson A.J. Jr. Clin, Pharmacol. Therap. 1975; 17: 134
- Reidenberg M., Drayer D.E., Levy M., Warner H. Clin. Pharmacol. Therap. 1975; 17: 722
- Buchanan R.A., Kinkel A.W., Goulet J.R., Smith T.C. Neurology 1972; 22: 126
- Melikian A.P., Straughn A.B., Slywka G. W.A. J. Pharmacokin. Biopharm. 1977; 5: 133
- Martin E., Tozer T.N., Sheiner L.B, Riegelman S. J. Pharmacokin. Biopharm. 1977; 5, 579
- Pindell M.H., Cull K.M., Doram K.M., Dickison H.L. J. Pharmacol. Exp, Therap. 1959; 125: 287
- Winne D. Pharmacol, Ther. 1979; 6: 333
- Prescott L.F. Brit. J. Clin. Pharmacol. 1974; 1: 189
- Boxenbaum H.G., Bekersky I., Jack M.L., Kaplan S.A. Drug Metab, Rev. 1979; 9: 259
- Finch J.E., Kendall M.J, Mitchard M. Brit. J. Clin. Pharmacol. 1974; 1: 233
- Nimmo W.S. Clin. Pharmacokin. 1976; 1: 189
- Heading R.C., Nimmo J., Prescott L.F., Tothill P. Brit. J. Pharmacol. 1973; 47: 415
- Mattok G.L., McGilveray I.J. Rev. Can. Biol. 1973; 32, (Suppl.), 77
- Boxenbaum H.G. G.S, Jodhka, A.C, Ferguson et al. J. Pharmacokin. Biopharm. 1974; 2, 211
- Eve I.S. Health Phys. 1966; 12: 131
- Schline R.R. Pharmacol. Rev. 1968; 25: 451